Evaluation of Viral Hepatitis B Treatment in Pointe-Noire in 2016

作     者：F. Bossali G. Ndziessi C. L. Ahoui-Apendi G. Deby M. J. F. Mimiesse J. W. Ombila B. I. Atipo-Ibara J. R. Ibara 

作者机构：Department of Gastroenterology Loandjili General Hospital Pointe-Noire Congo-Brazzaville Faculty of Health Sciences Department of Public Health Marien Ngouabi University Brazzaville Congo Department of Gastroenterology University Hospital of Brazzaville Brazzaville Congo 

出 版 物：《International Journal of Clinical Medicine》 (临床医学国际期刊（英文）)

年 卷 期：2018年第9卷第6期

页      面：513-519页

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：Access Congo Hepatitis B Pointe-Noire Treatment 

摘      要：Prevalence of hepatitis B in Pointe-Noire is 23%. The objective of this study was to evaluate the level of therapeutic management of patients with hepatitis B in Pointe-Noire. Methods: A retrospective, cross-sectional, descriptive and analytical study. Results: 302 patients included: 217 (72%) men and 85 (28%) women of median age 40 years. The viral load was measured in 140 (46%) patients and in 162 (54%), the viral load was not measured. Their distribution according to the viremia was as follows: 0 - 1 log = 1 (0.7%) patients;1.5 to 2 log = 23 (16%) patients;2.5 to 3 log = 49 (35%) patients;3log = 55 (39%) patients. Of the 302 patients included, 36 (11%) patients were treated with antivirals and 253 (83%) patients were not. Conclusion: The number of patients treated for chronic viral hepatitis B was low. Our results show interest for improved preventive and curative management of hepatitis B in Congo in order to reduce the existing high prevalence.